Clinical Trial Update: A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This entry covers a Phase 2, single-arm, open-label trial evaluating maintenance therapy with capecitabine plus cetuximab in metastatic colorectal cancer; no re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Xeloda (capecitabine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN